Supplemental material for JAAD publication titled: Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate to severe plaque psoriasis: 24 Week results from a Phase III open-label, randomized, multicenter study
收藏官方服务：
资源简介：
Supplemental material for JAAD publication titled: "Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate to severe plaque psoriasis: 24 Week results from a Phase III open-label, randomized, multicenter study" to be published in Journal of the American Academy of Dermatology
创建时间：
2020-11-12
